Boots WebMD Partners in Health
Return To Boots

Menopause health centre

HRT may offer women heart protection

Taking hormone replacement therapy lowers the risk of heart attacks without increasing cancer risk, a study finds
By Brenda Goodman
WebMD UK Health News
Medically Reviewed by Dr Rob Hicks
woman thinking

10th October 2012 - Hormone replacement therapy (HRT) may do more than ease symptoms of the menopause such as hot flushes and mood swings. A new study suggests that women who take HRT for 10 years following menopause have a significantly reduced risk of heart failure, heart attack or dying.

Furthermore, this benefit comes without any increased risk of cancer, deep vein thrombosis or stroke, says the paper published in the online edition of the BMJ.

However, experts caution that HRT may have long term health implications.

Risks versus benefits

HRT for postmenopausal women has been the subject of discussion and speculation since the 1960s. At first, HRT was thought to be mainly beneficial because it reduced cases of cardiovascular disease, osteoporosis and colon cancer. It was considered that these benefits outweighed the negative side effects of an increased risk of breast cancer and blood clots.

However, in 2002, results from the Women's Health Initiative (WHI) in the US found that HRT did not offer protection against cardiovascular disease.

These conflicting results led to what is known as the 'timing hypothesis'. The question was asked whether hormones from HRT might be safer and more beneficial if they are replaced as they naturally start to drop off, around the time of menopause, rather than introducing them later in life.

Researchers in Denmark have published the results of a trial into women given HRT early after the menopause. They randomly split 1,006 healthy women aged 45 to 58 into two groups: the first group got HRT; the second group got no treatment.

All the women in the study were near menopause and no more than two years away from their last menstrual period.

Stopped early

The trial was begun in the early 1990s and was designed to run for 20 years. However, researchers stopped it early - after about 10 years - once the results from the WHI and another trial emerged which reported that using HRT might result in more harm than benefit in postmenopausal women.

As a result, the women involved in the trial were advised to stop treatment.

However, the researchers continued to check on the women enrolled on the study for a further six years.

In contrast to what happened in the WHI, the Danish women who took HRT were less likely to die over the course of the study or be hospitalised because of a heart attack or heart failure.  After the 10 year period, 16 women who had received HRT either died, were admitted to hospital with heart failure or had a heart attack. That compared with 33 women who had been placed in the control group and had not received HRT.

The researchers also found that there were no meaningful differences in strokes, dangerous blood clots or cancers between the two groups.

Popular Slideshows & Tools on Boots WebMD

woman looking at pregnancy test
Early pregnancy symptoms
humbug hard candies
Diarrhoea & more
donut on plate
The truth about sugar addiction
cute dog
10 common allergy triggers
couple watching sunset
How much do you know?
hand extinguishing cigarette
13 best tips to stop smoking
assorted spices
Pump up the flavour with spices
crossword puzzle
Help for the first hard days
bag of crisps
Food cravings that wreck your diet
adult man contemplating
Visual guide to BPH
polka dot dress on hangar
Lose weight without dieting